Cervical Preparation With Mifepristone Prior to Osmotic Dilators

Phase 2 Terminated 44 enrolled University of California, Davis Society of Family Planning · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D\&E) procedures.

Timeline

Start: 2019-04-26
Primary completion: 2021-02-26
Completion: 2021-02-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mifepristone	Small molecule	200 mg	Oral

Indications

No indication recorded.